Effect of celecoxib on symptoms of patients with Schizophrenia under Electroconvulsive Therapy
Not Applicable
Recruiting
- Conditions
- Schizophrenia.
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 48
Inclusion Criteria
patients with Schizophrenia under Electroconvulsive Therapy
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Blood biochemical indicators: CBC diffWBCBaselin monocyte LymphocyteESRCRP. Timepoint: Before the start of shock therapy, the end of the third session and the end of the sessions. Method of measurement: Review of clinical findings.
- Secondary Outcome Measures
Name Time Method